Inhibitors of the renin-angiotensin system in diabetic patients with heart failure with preserved ejection fraction treatment: impact of m235t polymorphism of angiotensinogen

31 August 2019 (12:40 - 13:30)
Organised by:
Congress Presentation Part of: Novelties in pathophysiology of heart failure with preserved ejection fraction Pharmacotherapy ESC Premium Access ESC Congress 2019

ESC 365 is supported by

ESC 365 is supported by